Bio-Rad Laboratories BIO
NYSE BIO
$376.82 +12.55 (+3.45%)
At close: Aug 20, 2026 · 1:20 PM UTC

Bio-Rad Laboratories (BIO) Return on Sales Growth (3y) (2012 - 2026)

Bio-Rad Laboratories (BIO) Return on Sales Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn 0.00
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 0.00
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn 0.00
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn 0.00
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn 0.00
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn 0.00
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn 0.00
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 0.00
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 0.00
10 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn 2.00

Historic Data

Download Data
DateValue
Jun 30, 2026 2.00
Mar 31, 2026 -1.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 2.00
Mar 31, 2025 5.00
Dec 31, 2024 1.00
Sep 30, 2024 -4.00
Jun 30, 2024 -5.00
Mar 31, 2024 -1.00
Dec 31, 2023 -1.00
Sep 30, 2023 -2.00
Jun 30, 2023 -4.00
Mar 31, 2023 -1.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 -2.00
Mar 31, 2022 -6.00
Dec 31, 2021 -1.00
Sep 30, 2021 5.00